ARRIGO, Carmela
 Distribuzione geografica
Continente #
NA - Nord America 548
EU - Europa 439
AS - Asia 97
AF - Africa 1
Totale 1.085
Nazione #
US - Stati Uniti d'America 548
IE - Irlanda 147
SE - Svezia 134
CN - Cina 91
UA - Ucraina 57
DE - Germania 39
FI - Finlandia 20
GB - Regno Unito 20
BE - Belgio 15
IN - India 5
IT - Italia 5
LV - Lettonia 1
RU - Federazione Russa 1
SC - Seychelles 1
SG - Singapore 1
Totale 1.085
Città #
Dublin 147
Jacksonville 121
Chandler 113
Nyköping 76
Ann Arbor 52
Beijing 51
Ashburn 31
Princeton 22
Cambridge 19
Des Moines 16
Brussels 15
Medford 15
Dearborn 14
Woodbridge 10
Lancaster 9
Boardman 8
Wilmington 7
New York 6
Tianjin 5
Norwalk 4
Shenyang 4
Bremen 3
Haikou 3
Hangzhou 3
Hyderabad 3
Jinan 3
Taizhou 3
Washington 3
Changsha 2
Chicago 2
Florence 2
Guangzhou 2
Los Angeles 2
Messina 2
Nanchang 2
Pune 2
Seattle 2
Taiyuan 2
Zhengzhou 2
Auburn Hills 1
Clearwater 1
Hebei 1
Helsinki 1
Hongtong 1
Houston 1
Lanzhou 1
Munich 1
Ningbo 1
Phoenix 1
Qingdao 1
Redwood City 1
San Mateo 1
Totale 801
Nome #
CLINICAL ACTIVITY OF BORTEZOMIB IN RELAPSED OR REFRACTORY GASTRIC MARGINAL ZONE B-CELL LYMPHOMA OF MALT TYPE 72
Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST 71
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy. 70
Surgical treatment for congestive heart failure with autologous adult stem cell transplantation 66
An acute-leukaemia-like picture due to breast carcinoma cells. 64
Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes 62
Effect of treatment with amifostine in patients with myelodisplastic syndromes on clinical outcome and apoptosis in bone marrow 62
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report 60
Fatal delayed diagnosis in a patient with falciparum malaria 58
Amplification and overexpression of the PSMB5 gene contribute to Bortezomib resistance in re-treatment of patients with Multiple Myeloma 55
Myelodysplastic syndrome/acute myelogenous leukaemia after adjuvant chemotherapy with pyrimidine anti-metabolites in three patients 54
Severe pulmonary complications after bortezomib treatment for multiple myeloma: An unrecognized pulmonary vasculitis? 52
Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenoma. 46
ERLOTINIB IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA AND CONCOMITANT NON-SMALL-CELL LUNG CANCER 46
Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: a new case report 46
Salvage therapy for primary central nervous system lymphoma with Y-90-Ibritumomab and Temozolomide 44
Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms 44
Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF 44
DASATINIB INDUCES A RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA 43
How cells respond to interferons. 41
Totale 1.100
Categoria #
all - tutte 4.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/2020206 39 16 1 18 0 12 26 18 2 47 26 1
2020/2021130 23 0 31 10 2 18 3 16 1 14 7 5
2021/2022165 3 26 4 3 6 1 17 7 2 36 15 45
2022/2023422 29 56 26 22 31 38 5 29 168 2 13 3
2023/202477 8 9 9 22 2 20 0 1 0 5 0 1
Totale 1.100